D.R. Horton, Inc.’s Stock Price Drops to $120.81, Marking a 5.52% Decrease: A Deep Dive into the Construction Giant’s Performance

D.R. Horton, Inc. (DHI)

120.81 USD -7.06 (-5.52%) Volume: 5.99M

D.R. Horton, Inc.’s stock price is currently at 120.81 USD, experiencing a decrease of -5.52% in the latest trading session with a trading volume of 5.99M. With a year-to-date percentage change of -13.60%, DHI’s stock performance continues to be a point of interest for investors.

Latest developments on D.R. Horton, Inc.

Dr Horton Inc stock experienced underperformance on Monday in comparison to its competitors, despite moving 4.6% higher recently. The company is making strides in development, with plans for 288 units in Gloucester County and a subdivision review scheduled for May. Despite recent challenges, analysts at Citigroup have adjusted Dr Horton’s price target to $140 from $151, maintaining a neutral rating. This adjustment may have influenced today’s stock price movements as investors react to the company’s future prospects.

D.R. Horton, Inc. on Smartkarma

Analyst coverage of Dr Horton Inc on Smartkarma by Baptista Research shows a bullish sentiment towards the company. In their report titled “D.R. Horton: Adaptation to Market Trends Powering Our Bullishness! – Major Drivers,” they highlight the company’s financial performance for the first quarter of fiscal 2025. Despite a decrease in earnings per diluted share compared to the prior year, Dr Horton Inc generated consolidated revenues of $7.6 billion with a pretax profit margin of 14.6%. This indicates both strengths and challenges facing the company as they navigate market trends.

Another report by Baptista Research on Smartkarma, titled “D.R. Horton: How Are They Adapting Pricing and Incentives in Response to Market Conditions? – Major Drivers,” delves into the company’s fiscal year and quarter ending in 2024. Despite market challenges, Dr Horton Inc, known as America’s largest homebuilder, maintained a solid performance with strong revenue figures. The fourth quarter saw consolidated revenue reach $10 billion and a pre-tax profit margin of 17.1%, showcasing consistent profitability year-over-year. This analysis provides valuable insights into how Dr Horton Inc is adapting to market conditions to drive growth.

A look at D.R. Horton, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Looking ahead, Dr Horton Inc seems to have a positive long-term outlook based on its Smartkarma Smart Scores. With a strong Growth score of 4, the company is expected to continue expanding and increasing its market share in the construction and real estate industry. Additionally, both the Resilience and Momentum scores are at 4, indicating that Dr Horton Inc has the ability to weather economic downturns and maintain its upward trajectory in the market.

While Dr Horton Inc may not be the top choice for investors seeking high dividends, with a score of 2 in that category, the company still offers value with a score of 3. This suggests that Dr Horton Inc‘s stock may be undervalued compared to its potential for growth and resilience. Overall, Dr Horton Inc‘s diversified operations and focus on providing affordable housing options position it well for continued success in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma